157 related articles for article (PubMed ID: 37904212)
21. Adjuvant therapy after resection of brain metastases. Frameless image-guided LINAC-based radiosurgery and stereotactic hypofractionated radiotherapy.
Broemme J; Abu-Isa J; Kottke R; Beck J; Wiest R; Malthaner M; Schmidhalter D; Raabe A; Aebersold DM; Pica A
Strahlenther Onkol; 2013 Sep; 189(9):765-70. PubMed ID: 23934329
[TBL] [Abstract][Full Text] [Related]
22. Impact of adjuvant fractionated stereotactic radiotherapy dose on local control of brain metastases.
Musunuru HB; Witt JS; Yadav P; Francis DM; Kuczmarska-Haas A; Labby ZE; Bassetti MF; Howard SP; Baschnagel AM
J Neurooncol; 2019 Nov; 145(2):385-390. PubMed ID: 31606876
[TBL] [Abstract][Full Text] [Related]
23. The Incidence and Its Associated Factors Relevant to Brain Radionecrosis That Requires Intervention Following Single or Fractionated Stereotactic Radiosurgery Using Vero4DRT for Brain Metastases.
Yamada T; Ohtakara K; Kamomae T; Itoh J; Shimada H; Ishihara S; Naganawa S
Cureus; 2022 Jun; 14(6):e25888. PubMed ID: 35844334
[TBL] [Abstract][Full Text] [Related]
24. Dosimetric quality and delivery efficiency of robotic radiosurgery for brain metastases: Comparison with C-arm linear accelerator based plans.
Zhang S; Yang R; Wang X
J Appl Clin Med Phys; 2019 Nov; 20(11):104-110. PubMed ID: 31580532
[TBL] [Abstract][Full Text] [Related]
25. The Effect of Biologically Effective Dose and Radiation Treatment Schedule on Overall Survival in Stage I Non-Small Cell Lung Cancer Patients Treated With Stereotactic Body Radiation Therapy.
Stahl JM; Ross R; Harder EM; Mancini BR; Soulos PR; Finkelstein SE; Shafman TD; Dosoretz AP; Evans SB; Husain ZA; Yu JB; Gross CP; Decker RH
Int J Radiat Oncol Biol Phys; 2016 Dec; 96(5):1011-1020. PubMed ID: 27869080
[TBL] [Abstract][Full Text] [Related]
26. Linac-based radiosurgery or fractionated stereotactic radiotherapy with flattening filter-free volumetric modulated arc therapy in elderly patients : A mono-institutional experience on 110 brain metastases.
Gregucci F; Fiorentino A; Corradini S; Figlia V; Mazzola R; Ricchetti F; Ruggieri R; Alongi F
Strahlenther Onkol; 2019 Mar; 195(3):218-225. PubMed ID: 30478669
[TBL] [Abstract][Full Text] [Related]
27. Stereotactic ablative radiation therapy for brain metastases with volumetric modulated arc therapy and flattening filter free delivery: feasibility and early clinical results.
Fiorentino A; Giaj-Levra N; Tebano U; Mazzola R; Ricchetti F; Fersino S; Di Paola G; Aiello D; Ruggieri R; Alongi F
Radiol Med; 2017 Sep; 122(9):676-682. PubMed ID: 28447313
[TBL] [Abstract][Full Text] [Related]
28. Effect of stereotactic body radiotherapy dose escalation plus pembrolizumab and trametinib versus stereotactic body radiotherapy dose escalation plus gemcitabine for locally recurrent pancreatic cancer after surgical resection on survival outcomes: A secondary analysis of an open-label, randomised, controlled, phase 2 trial.
Zhu X; Liu W; Cao Y; Ju X; Zhao X; Jiang L; Ye Y; Zhang H
EClinicalMedicine; 2023 Jan; 55():101764. PubMed ID: 36471691
[TBL] [Abstract][Full Text] [Related]
29. Dosimetric feasibility of brain stereotactic radiosurgery with a 0.35 T MRI-guided linac and comparison vs a C-arm-mounted linac.
Slagowski JM; Redler G; Malin MJ; Cammin J; Lobb EC; Lee BH; Sethi A; Roeske JC; Flores-Martinez E; Stevens T; Yenice KM; Green O; Mutic S; Aydogan B
Med Phys; 2020 Nov; 47(11):5455-5466. PubMed ID: 32996591
[TBL] [Abstract][Full Text] [Related]
30. Stereotactic Body Radiation Therapy for Pulmonary Metastasis from Colorectal Adenocarcinoma: Biologically Effective Dose 150 Gy is Preferred for Tumour Control.
Lee TH; Kang HC; Chie EK; Kim HJ; Wu HG; Lee JH; Kim KS
Clin Oncol (R Coll Radiol); 2023 Jun; 35(6):e384-e394. PubMed ID: 37003842
[TBL] [Abstract][Full Text] [Related]
31. Inhomogeneous tumor dose distribution provides better local control than homogeneous distribution in stereotactic radiotherapy for brain metastases.
Lucia F; Key S; Dissaux G; Goasduff G; Lucia AS; Ollivier L; Pradier O; Schick U
Radiother Oncol; 2019 Jan; 130():132-138. PubMed ID: 30017105
[TBL] [Abstract][Full Text] [Related]
32. Radiation necrosis and therapeutic outcomes in patients treated with linear accelerator-based hypofractionated stereotactic radiosurgery for intact intracranial metastases.
Zhang Q; Hamilton D; Conway P; Xie SJ; Haghighi N; Lasocki A
J Med Imaging Radiat Oncol; 2023 Apr; 67(3):308-319. PubMed ID: 36847751
[TBL] [Abstract][Full Text] [Related]
33. Acute toxicities and cumulative dose to the brain of repeated sessions of stereotactic radiotherapy (SRT) for brain metastases: a retrospective study of 184 patients.
Kuntz L; Le Fèvre C; Jarnet D; Keller A; Meyer P; Thiery A; Cebula H; Noel G; Antoni D
Radiat Oncol; 2023 Jan; 18(1):7. PubMed ID: 36627646
[TBL] [Abstract][Full Text] [Related]
34. Comparison of WBRT alone, SRS alone, and their combination in the treatment of one or more brain metastases: Review and meta-analysis.
Khan M; Lin J; Liao G; Li R; Wang B; Xie G; Zheng J; Yuan Y
Tumour Biol; 2017 Jul; 39(7):1010428317702903. PubMed ID: 28675121
[TBL] [Abstract][Full Text] [Related]
35. Dose-response relationships for radiotherapy of brain metastases: role of intermediate-dose stereotactic radiosurgery plus whole-brain radiotherapy.
Nieder C; Nestle U; Walter K; Niewald M; Schnabel K
Am J Clin Oncol; 2000 Dec; 23(6):584-8. PubMed ID: 11202802
[TBL] [Abstract][Full Text] [Related]
36. Planning Target Volume D95 and Mean Dose Should Be Considered for Optimal Local Control for Stereotactic Ablative Radiation Therapy.
Zhao L; Zhou S; Balter P; Shen C; Gomez DR; Welsh JD; Lin SH; Chang JY
Int J Radiat Oncol Biol Phys; 2016 Jul; 95(4):1226-35. PubMed ID: 27209498
[TBL] [Abstract][Full Text] [Related]
37. Stereotactic radiosurgery for intracranial metastases: linac-based and gamma-dedicated unit approach.
Alongi F; Fiorentino A; Mancosu P; Navarria P; Giaj Levra N; Mazzola R; Scorsetti M
Expert Rev Anticancer Ther; 2016 Jul; 16(7):731-40. PubMed ID: 27186849
[TBL] [Abstract][Full Text] [Related]
38. Optically-guided frameless linac-based radiosurgery for brain metastases: clinical experience.
Nath SK; Lawson JD; Wang JZ; Simpson DR; Newman CB; Alksne JF; Mundt AJ; Murphy KT
J Neurooncol; 2010 Mar; 97(1):67-72. PubMed ID: 19701719
[TBL] [Abstract][Full Text] [Related]
39. Dosimetric characterization of hypofractionated Gamma Knife radiosurgery of large or complex brain tumors versus linear accelerator-based treatments.
Dong P; Pérez-Andújar A; Pinnaduwage D; Braunstein S; Theodosopoulos P; McDermott M; Sneed P; Ma L
J Neurosurg; 2016 Dec; 125(Suppl 1):97-103. PubMed ID: 27903198
[TBL] [Abstract][Full Text] [Related]
40. Resection followed by stereotactic radiosurgery to resection cavity for intracranial metastases.
Do L; Pezner R; Radany E; Liu A; Staud C; Badie B
Int J Radiat Oncol Biol Phys; 2009 Feb; 73(2):486-91. PubMed ID: 18922650
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
